SLE Subgroups at Risk for Poor Outcomes After Hydroxychloroquine Taper or Discontinuation

被引：0
|
作者：
Almeida-Brasil, Celline [1 ]
Vinet, Evelyne [1 ]
Pineau, Christian [1 ]
Kalache, Fares [1 ]
Grenier, Louis-Pierre [1 ]
Bernatsky, Sasha [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
102
引用
收藏
页码：1079 / 1079
页数：1
相关论文
共 50 条
  • [1] Identification of SLE Subgroups at Risk for Poor Outcomes After Hydroxychloroquine Taper or Discontinuation
    Almeida-Brasil, Celline C.
    Vinet, Evelyne
    Pineau, Christian
    Bernatsky, Sasha
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal
    Trefond, Ludovic
    Mathian, Alexis
    Lhote, Raphael
    De Chambrun, Marc Pineton
    Pha, Micheline
    Hie, Miguel
    Miyara, Makoto
    Papo, Matthias
    Moyon, Quentin
    Taieb, Dov
    Abdallah, Nassim Ait
    Chasset, Francois
    Aubart, Fleur Cohen
    Haroche, Julien
    Zahr, Noel
    Amoura, Zahir
    JOINT BONE SPINE, 2024, 91 (06)
  • [3] Outcomes After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
    Almeida-Brasil, Celline
    Hanly, John
    Urowitz, Murray
    Clarke, Ann
    Ramsey-Goldman, Rosalind
    Gordon, Caroline
    Petri, Michelle
    Ginzler, Ellen M.
    Wallace, Daniel J.
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Dooley, Mary Ann
    Peschken, Christine A.
    Isenberg, David
    Rahman, Anisur
    Manzi, Susan
    Jacobsen, Soren
    Lim, S. Sam
    Van Vollenhoven, Ronald
    Nived, Ola
    Jonsen, Andreas
    Kamen, Diane
    Aranow, Cynthia
    Ruiz-Irastorza, Guillermo
    Sanchez-Guerrero, Jorge
    Gladman, Dafna
    Fortin, Paul
    Alarcon, Graciela
    Merrill, Joan
    Kalunian, Kenneth
    Ramos-Casals, Manuel
    Steinsson, Kristjan
    Zoma, Asad
    Askanase, Anca
    Khamashta, Munther
    Bruce, Ian
    Inanc, Murat
    Bernatsky, Sasha
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] Outcomes After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
    Almeida-Brasil, Celline
    Hanly, John
    Urowitz, Murray
    Clarke, Ann
    Ramsey-Goldman, Rosalind
    Gordon, Caroline
    Petri, Michelle
    Ginzler, Ellen
    Wallace, Daniel
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Dooley, Mary
    Peschken, Christine
    Isenberg, David
    Rahman, Anisur
    Manzi, Susan
    Aranow, Cynthia
    Sanchez-Guerrero, Jorge
    Gladman, Dafna
    Fortin, Paul
    Alarcon, Graciela
    Merrill, Joan
    Khamashta, Munther
    Bruce, Ian
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1137 - 1138
  • [5] High cholesterol level is a risk factor for poor outcomes in SLE
    Nature Clinical Practice Rheumatology, 2006, 2 (10): : 523 - 524
  • [6] Hydroxychloroquine concentrations persist after drug discontinuation
    Reactions Weekly, 2022, 1908 (1) : 9 - 9
  • [7] PNEUMOCYSTIS-CARINII PNEUMONIA FOLLOWING THE DISCONTINUATION OF HYDROXYCHLOROQUINE IN 2 PATIENTS WITH SLE
    PODREBARAC, T
    JOVAISAS, A
    KARSH, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : R36 - R36
  • [8] Hydroxychloroquine dose: balancing toxicity and SLE flare risk
    Tiphaine Lenfant
    Nathalie Costedoat-Chalumeau
    Nature Reviews Rheumatology, 2023, 19 : 6 - 7
  • [9] Hydroxychloroquine dose: balancing toxicity and SLE flare risk
    Lenfant, Tiphaine
    Costedoat-Chalumeau, Nathalie
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (01) : 6 - 7
  • [10] Hydroxychloroquine in systemic lupus: Drug tapering/discontinuation and clinical outcomes
    Almeida-Brasil, Celline C.
    Moura, Cristiano S.
    Vinet, Evelyne
    Pineau, Christian A.
    Lukusa, Luck
    Bernatsky, Sasha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 268 - 269
12345